Stock Market Manager Weekly Update: May 10th, 2022

Weekly UpdateMay 10, 2022

Black Swan Connection Newsletter Signup

Breaking News

Oil prices are up at as well as at the pump and driving inflation across the board. The unseen cost is related to Diesel that is now at an all-time high. That is a major part of transportation costs. According to Cowen/AFS data, the average fuel charge among LTL carriers grew from 28.3% in the fourth quarter last year to 42.1% in March. That just doesn’t affect trucking, but rail, ocean and every form of heavy transport that exists. As well a huge chunk of manufacturing costs are for all types of plastics and other petroleum based products that again move lock step with oil prices. The cure for this is a national energy policy that ensures we are energy independent, not wishful thinking or sucking up to Opec. And oh yes, Ocasio and others who live in an electric world dreamland that is decades away, you are going to pay dearly for your lack of understanding about what makes our world go round, like truck and tractor tires.

Aint none of this good for the stock markets……….

Market watch 5-10-22

Stock Market Bounce Fades As S&P 500 Trims Gain To Just 0.3%

The stock market tried to bounce back after a three-day sell-off, but sharp gains at the open faded after the first 90 minutes of trading. The limp action suggested the market is not ready to rebound.

The Nasdaq recovered more than 2% early on, but pared its gain to 0.5% at 11 a.m. ET. The S&P 500 held to a 0.3% gain. The Dow Jones Industrial Average rose 0.1% after rising more than 1%. Tech heavyweights Apple (AAPL), Microsoft (MSFT), Alphabet (GOOGL) and Nvidia (NVDA) pared gains to 1.5% to 2.5%.

The Nasdaq’s 4.3% loss Monday marked a three-day losing streak of more than 10%. It was the largest three-day decline since March 2020.

Today’s volume rose on the NYSE and Nasdaq compared with the same time on Monday. Crude oil prices were little changed. The yield on the 10-year Treasury note fell 12 basis points to 2.95%, dropping below 3% for the first time since Thursday.Stock Market Bounce Fades As S&P 500 Trims Gain To Just 0.3%

Read full report here

Corporate News

Sponsored by:

The 21st Century Investment Bank Capital Raises + Strategic Advisory

Donald Capital is a boutique Investment Bank that focuses on raising capital for emerging growth companies in the U.S. and around the globe.

Ideally, we like to work with Private and Public companies with a good management team, a compelling business plan, and the ability to gain market share.

For more information go to:

The Premier Operating System for Publicly Traded Companies

Track your investors’ buying and selling behaviors and use those insights to engage them across marketing channels.

Know who’s buying and selling and monitor trading in real time. Unlock your shareholders contact info and build full contact profiles on your shareholders, including emails, phone numbers, and social media accounts to engage them and target new investors through media campaigns.

Click Here For a Sequire Power Point Presentation

To schedule a demo email me at or call 727-459-7378

5-2-2022 Antibe Therapeutics, Inc. (OTCQX: ATBPF)
Antibe Therapeutics Announces Strategic Sale of Citagenix Subsidiary

– $6.5 million all-cash transaction, including milestone payments

– Enables exclusive focus on drug pipeline

TORONTO, May 02, 2022–(BUSINESS WIRE)–Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical stage company leveraging its hydrogen sulfide platform to develop next-generation safer therapies that target inflammation, is pleased to announce the signing of a binding agreement to sell its Citagenix Inc. subsidiary to HANSAmed Limited (“HANSAmed”), a leading Canadian full-service distributor of pharmaceuticals and medical devices to dental professionals.

Read Complete Report

4-19-2022 Coeptis Therapeutics, Inc. OTC COEP

Coeptis Therapeutics, Inc. and Bull Horn Holdings Corp. Announce Merger Agreement

Transaction expected to accelerate Coeptis’ ability to progress its innovative cell therapy platforms for cancer

David Mehalick of Coeptis to serve as Chief Executive Officer;
Chris Calise of Bull Horn to join the Board of Directors

Merger anticipated to close in third quarter 2022; combined company anticipated to list on Nasdaq

WEXFORD, Pa., and MIAMI, Fla., April 19, 2022 /PRNewswire/ — Coeptis Therapeutics, Inc. (OTC PINK: COEP) (“Coeptis” or “the Company”), a biopharmaceutical company developing innovative cell therapy platforms for cancer, and Bull Horn Holdings Corp. (Nasdaq: BHSE) (“Bull Horn”), a special purpose acquisition company (SPAC), today announced they have entered into a definitive merger agreement for a business combination that will result in Coeptis becoming a wholly-owned subsidiary of Bull Horn. Under the terms of the merger agreement, a wholly-owned subsidiary of Bull Horn will merge with and into Coeptis and the holders of the outstanding Coeptis shares will receive equity in Bull Horn valued at $175 million (subject to adjustments).

Read Complete Report

04-13-2022 Coeptis Therapeutics, Inc. OTC COEP
Statera Biopharma and Coeptis Therapeutics Announce Strategic Agreement for Rights to Entolimod

FORT COLLINS, Colo., April 13, 2022 (GLOBE NEWSWIRE) — Statera Biopharma (Nasdaq: STAB) (the “Company”), a biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, announced today that the Company has agreed to enter into a strategic agreement with Coeptis Therapeutics, Inc. (OTC PINK: COEP), a biopharmaceutical company developing innovative cell therapy platforms for cancer, to sell Statera’s rights to Entolimod and other related toll-like receptor 5 (TLR5) agonists. The consummation of the transaction is contingent upon negotiation of a definitive agreement and satisfaction of a number of closing conditions, including a contingency on Coeptis financing.

Read Complete Report

3-30-2022 SRAX (NASDAQ: SRAX)
SRAX To Host the LD Micro Invitational at the Four Seasons Hotel in Westlake Village, CA

LOS ANGELES, March 30, 2022 (GLOBE NEWSWIRE) — SRAX, Inc. (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS platform, will host the 2022 LD Micro Invitational, a prominent 3-day investor conference, at the Four Seasons Hotel Westlake Village on June 7th-9th, 2022.

LD Micro is host to the most influential conferences in the small and microcap world. Chris Lahiji, founder of the prestigious function, notes the success of the Main Event last October as a “great success that restored humanity within our industry. People could finally see each other and connect again in person. As a result, the upcoming Invitational was the fastest sell-out in our history.”

Read full Report

3-29-2022 SRAX (NASDAQ: SRAX)
SRAX to Host Full Year and Q4 2021 Conference Call on April 4th, 2022

LOS ANGELES, March 29, 2022 (GLOBE NEWSWIRE) — SRAX, Inc. (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS platform, is scheduled to host a conference call to discuss its Full Year and Q4 2021 results on Monday, April 4th.

Conference Call:

SRAX’s Founder and CEO, Christopher Miglino, and CFO, Michael Malone, will provide a summary of Q4 2021, as well as the full year, on a video call this Monday, April 4th, at 4:30 pm ET / 1:30pm PT. This will include a live question and answer session at the end of the call. Those interested in submitting questions in advance can do so by emailing

To register for the live webcast and view the presentation, please sign up here:

To access the conference by phone:

Dial-in: +1 3462487799
Meeting ID: 92478894626
Passcode: 223670

About SRAX

SRAX (NASDAQ: SRAX) is a financial technology company that unlocks data and insights for publicly traded companies. Through its premier investor intelligence and communications platform, Sequire, companies can track their investors’ behaviors and trends and use those insights to engage current and potential investors across marketing channels. For more information on SRAX, visit and .

New on the Scene is Ecrid, Inc. taking on the establishment with a new and improved credit reporting system.

Check it out!!

10-15 2021 Ecrid, Inc  (OTC ECDD)
ECRID, the New Credit Bureau Files New IPO

STUART, Fla. , Oct. 15, 2021 /PRNewswire/ — ECRID (OTC: ECDD) is the New Credit Bureau ( ) that offers each member the opportunity to create their own personal ECRID Credit Report with conventional and unconventional creditors that they have paid on time to validate their credit worthiness (rental payments included) to lenders. Each Credit Report Holder starts out with a Perfect 950 Credit Score.

An ECRID executive said, “We’re extremely excited and thrilled to prepare to launch one of the most exciting and novel Fintech Credit Lending platforms of its kind, at a time where a large percentage of adults have cash flow, but unfortunately deemed to have poor credit scores.”

First, ECRID Bill Pay Service is second to none. ECRID Credit Report Holders will pay their monthly bills listed on their ECRID Credit Report, through an automated ECRID Electronic Payment System. Once payment is processed, the ECRID Credit Score and payment status will update in real time on the ECRID User’s Credit Report. This process and method gives Lenders validation on how each ECRID Credit Report Holder pays their bills. Secondly, ECRID Credit Report Holders will be able to apply for loans (Home, Auto & Personal loans) inside their ECRID Business Center. Lenders will have access to sign up at to become a member and offer their services to the ECRID Credit Report Holders who are looking for financing. The goal is to start offering lending services in November 2021 . ECRID Lenders will be asked not to pull an Equifax, Experion, or Transunion credit report, but instead, base their Novel Fintech Sector Lending on the actual individual user’s ECRID Credit Report. This will give the ECRID User (borrower) a fresh start and a second chance at reestablishing themselves as credit-worthy borrowers. The company’s (ECRID) primary objective is to base the lending decision on the user’s (borrower) ECRID Credit Report along with the user’s (borrower) income-to-debt ratio.

See Complete Release

03-07-2021 CanB Corp (OTC  CANB)

Greenridge Global Research update

Up To 100 CBD Lab Lounges To Be Launched

Up To 100 CBD Lab Lounges To Be Launched.  Yesterday, the Company announced a ten-year deal with American Development Partners (“ADP”) to finance and develop up to 100 CBD Lounges, similar to CANB’s Lab2 format at its Miami facility.  The Lab2 concept, which is nearing completion, features a bar/lounge consumption area with viewing windows to see products, like gummies and gelato, being made.  The ADP-developed lounges are expected to be similar, having a bar/lounge space with viewing windows to see various end products being produced.  The lounges will serve CANB as a relatively cheap way to establish regional production and distribution, enable it to build its brands on a national level, engage in a wider range of product R&D, and increase branded product sales in the lounges.  ADP has budgeted $4 million for each lounge (committing $200 million with an option for another $200 million), and will receive a 10% development fee and a 20-year lease on each lounge from CANB.  No additional details were released, other than the Company noting no equity was involved in the deal.  ADP has a history of real estate development projects, with clients ranging from Wendy’s, Subway, Hampton Inn, Gold’s Gym, and AutoZone, among many other nationwide chains.

Read Complete Report

01-20-2022 Coeptis Therapeutics, Inc. OTC COEP

Coeptis Therapeutics Establishes Scientific Advisory Board to Advance Cell Therapy Product Development

Newly formed Scientific Advisory Board includes three members from the prestigious Karolinska Institutet (KI)

WEXFORD, Pa., Jan. 20, 2022 /PRNewswire/ — Coeptis Therapeutics, Inc. (OTC PINK: COEP), a biopharmaceutical company developing innovative cell therapy platforms for cancer, today announces the formation of its Scientific Advisory Board (SAB), which will contribute key guidance on the advancement of the Company’s product portfolio highlighted by CD38-GEAR-NK, a cell therapy technology, and CD38-Diagnostic, an in vitro diagnostic, which the company is co-developing with VyGen-Bio, Inc.

The Scientific Advisory Board is comprised initially of three renowned scientific researchers from the Karolinska Institutet, Stockholm, Sweden; Evren Alici, M.D., Ph.D.; Hans-Gustaf Ljunggren, M.D., Ph.D; and Arnika Kathleen Wagner, Ph.D.

Read Complete Release

Alternative Investments

Check out our latest commercial properties including an Amazing Private Island or Resort Development Property in Panama

3700 Acre Private Island in the Las Perlas Islands

7.4 Acre beachfront paradise for development or private retreat

Message me on Linkedin and check our latest commercial listings:

Please subscribe to our newsletter to get ongoing Real Estate and Alternative Investing updates:

Black Swan Connection Newsletter Signup

May 10, 2022
Coeptis Therapeutics, Inc. Ecrid, Inc (ECDD)   Profile        
Antibe Therapeutics, Inc (ATBPF)  Profile 11/11/2018 News
Can B Corp (CANB) Profile News
Endurance Exploration Group, Ltd (EXPL)  Profile   03-26/19 News
Social Reality, Inc. (SRAX) Profile News              

May 6, 2022
ValuEngine Weekly Report

Why Pay More for Your Investments?

May 6, 2022 by Herb Blank

Consumers have never been happy about paying more for the same (or less) from one place than from another.  It has only been within the past twenty years or so that investors have gotten wiser to this practice. Financial advisors, planners and the media have increasingly made investors more aware of how much less expensive and tax-efficient ETFs are than mutual funds using the traditional redeem-at-distributor structure.  When one adds in tax-efficiency, faster clearing and settlement, intraday liquidity and zero redemption fees, there is almost no reason to pay up for new purchases of traditionally structured mutual funds.
Read Complete Report

ValuEngine new strategies, Podcast introduction

ValuEngine Capital Management LLC (VECM) is pleased to announce the addition of Jordan Kimmel to the team as the new Chief Equity Strategist and portfolio manager. VECM is a Registered Investment Advisor (RIA) that invests based on the proprietary, quantitative research produced by ValuEngine Inc. It is an important partnership between two companies: ValuEngine conducts research, and ValuEngine Capital Management LLC actively trades client funds using this research.



To subscribe to our bulletins and receive content whenever it is published, subscribe at our blog HERE

Want to learn more about ValuEngine? Our methods? Our history? 
Check out our video presentation HERE

SMM Research Partners

Black Swan Research Coverage and Subscription Service
Click Here>>

Event Calendar Updates

SRAX To Host the LD Micro Invitational at the Four Seasons Hotel in Westlake Village, CA

LOS ANGELES, March 30, 2022 (GLOBE NEWSWIRE) — SRAX, Inc. (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS platform, will host the 2022 LD Micro Invitational, a prominent 3-day investor conference, at the Four Seasons Hotel Westlake Village on June 7th-9th, 2022.

For more information on LD Micro, visit

Rocky Mountain Microcap Conference IX.

Event will be held May 25,  2022 conference at TopGolf in Centennial Colorado

As with past conferences, Rocky Mountain Microcap Conference IX will be a single-track, single day, 13 company event.  Each presenter will be allotted 25-minutes and we expect the conference to run from approximately 10 am until 5:30 pm followed by drinks, dinner and golf.  Lunch will be served as well.  Unlike, like our past few events, this conference we will be an in-person event only as we will not be providing a virtual option.

Visit our homepage for up to the minute Financial News, Quotes and our Latest Black Swan Connection Newsletter

Stock Market Manager Homepage

-SMM Distribution Update-

Distribution (Reach)

SMM Global Twitter Acct     (Impressions last 30 days)          520

SMM Global Facebook Page  (Reach last-30 days)               6,462

SMM Linkedin Pages                 (contacts)                          1,100

SMM Youtube Channel            (followers)                                 6 

SMM Instagram Page  *          (followers)                               11

Direct Email     *                                                          220,000

Total                                                                           256,460

Black Swan Connection Newsletter Signup